LIGHT Trial focuses on lowering IOP, keeping it there.

Detalles Bibliográficos
Publicado en:Ophthalmology Times Vol. 44; no. 19; pp. 18 - 19
Autor principal: Gazzard, Gus
Formato: pictorial Journal Article
Publicado: MJH Life Sciences Nov2019
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=139818271&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 139818271
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        0193032X
        OTI
      jtl: Ophthalmology Times
      issn: 0193032X
      maglogo: N
    pubinfo:
      dt: Nov2019
      vid: 44
      iid: 19
      pid: 54670
      pub: MJH Life Sciences
      place: Cranbury, New Jersey
    artinfo:
      ui:
        139818271
        139818271
        139818271
        139818271
      ppf: 18
      ppct: 1
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: LIGHT Trial focuses on lowering IOP, keeping it there.
      aug:
        au: Gazzard, Gus
        affil: National Institute for Health Research- Health Technology Assessment
      sug:
        subj:
          Repeat Procedures Methods
          Laser Therapy Methods
          Trabeculectomy Methods
          Glaucoma Surgery
          Ocular Hypertension Surgery
          Intraocular Pressure Evaluation
          Treatment Outcomes
          Glaucoma Diagnosis
          Ocular Hypertension Diagnosis
          Treatment Failure
          Severity of Illness
      pubtype: Trade Publication
      doctype:
        pictorial
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N